Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 3, 2007, Pages 1123-1125

  Wardak, Sebastian ^a   Szych, Jolanta ^a   Zasada, Aleksandra Anna ^a   Gierczyński, Rafał ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ERYTHROMYCIN; ISOLEUCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; THREONINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; GENE AMPLIFICATION; NONHUMAN; POLAND; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TETO GENE;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLAND; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TETRACYCLINE RESISTANCE;

EID: 33847611542     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01187-06     Document Type: Article

References (21)

1. Alonso, R., E. Mateo, C. Girban, E. Churruca, I. Martinez, and A. Fernández-Astorga. 2004. PCR-restriction fragment length polymorphism assay for detection of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli. Antimicrob. Agents Chemother. 48:4886-4888.
2. Bacon, D. J., R. A. Alm, D. H. Burr, L. Hu, D. J. Kopecko, C. P. Ewing, T. J. Trust, and P. Guerry. 2000. Involvement of a plasmid in virulence of Campylobacter jejuni 81-176. Infect. Immun. 68:4384-4390.
3. Batchelor, R. A., B. M. Pearson, L. M. Friss, P. Guerry, and J. M. Wells. 2004. Nucleotide sequences and comparison of two large plasmids from different Campylobacter species. Microbiology 150:3507-3517.
4. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing. Informational supplement M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved guideline M45-A. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Edmonds, P., B. Hall, W. Edwards, and K. M. Hartline. 1992. Presence of methylated adenine in GATC sequences in chromosomal DNAs from Campylobacter species. J. Bacteriol. 174:8156-8157.
7. Friedman, C. R., J. Neimann, H. C. Wegener, and R. V. Tauxe. 2000. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations, p. 121-138. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter, 2nd ed. ASM Press, Washington, DC.
8. Gibreel, A., D. M. Tracz, L. Nonaka, T. M. Ngo, S. R. Connell, and D. E. Taylor. 2004. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob. Agents Chemother. 48:3442-3450.
9. Gierczyński, R., S. Kałużewski, A. Rakin, M. Jagielski, A. Zasada, A. Jakubczak, B. Borkowska-Opacka, and W. Rastawicki. 2004. Intriguing diversity of Bacillus anthracis in eastern Poland-the molecular echoes of the past outbreaks. FEMS Microbiol. Lett. 239:235-240.
10. Iovine, N. M., and M. J. Blaser. 2004. Antibiotics in animal feed and spread of resistant Campylobacter from poultry to humans. Emerg. Infect. Dis. 10:1158-1159.
11. Lee, C.-Y., C.-L. Tai, S.-C. Lin, and Y.-T. Chen. 1994. Occurrence of plasmids and tetracycline resistance among Campylobacter jejuni and Campylobacter coli isolated from whole market chickens and clinical samples. Int. J. Food Microbiol. 24:161-170.
12. Nirdnoy, W., C. J. Mason, and P. Guerry. 2005. Mosaic structure of a multiple-drug-resistant, conjugative plasmid from Campylobacter jejuni. Antimicrob. Agents Chemother. 49:2454-2459.
13. Piddock, L. J., V. Ricci, L. Pumbwe, M. J. Everett, and D. J. Griggs. 2003. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J. Antimicrob. Chemother. 51:19-26.
14. Prats, G., B. Mirelis, T. Llovet, C. Munoz, E. Miró, and F. Navarro. 2000. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob. Agents Chemother. 44:1140-1145.
15. Pratt, A., and V. Korolic. 2005. Tetracycline resistance of Australian Campylobacter jejuni and Campylobacter coli isolates. J. Antimicrob. Chemother. 55:452-460.
16. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. Taylor, D. E., M. A. DeGrandis, D. A. Karmali, and P. C. Fleming. 1981. Transmissible plasmids from Campylobacter jejuni. Antimicrob. Agents Chemother. 19:831-835.
18. Unicomb, L. E., J. Ferguson, R. J. Stafford, R. Ashbolt, M. D. Kirk, N. G. Becker, M. S. Patel, G. L. Gilbert, M. Valcanis, and L. Mickan. 2006. Low level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. Clin. Infect. Dis. 42:1368-1374.
19. Wagner, J., M. Jabbusch, M. Eisenblätter, H. Hahn, C. Wendt, and R. Ignatius. 2003. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrob. Agents Chemother. 47:2358-2361.
20. Wardak, S., J. Szych, and A. Cieślik. 2005. Detection of mutation in the gyrA gene at position 86-Thr associated with fluoroquinolone resistance in Campylobacter jejuni using PCR-restriction fragment length polymorphism assay. Med. Dosw. Mikrobiol. 57:295-301.
21. Wassenaar, T. M., N. M. C. Bleumink-Pluym, and B. A. M. van der Zeijst. 1991. Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J. 10:2055-2061.